Riuko Ohashi

2.7k total citations
72 papers, 1.7k citations indexed

About

Riuko Ohashi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Riuko Ohashi has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 26 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Riuko Ohashi's work include Renal cell carcinoma treatment (12 papers), Renal and related cancers (9 papers) and Cancer Genomics and Diagnostics (8 papers). Riuko Ohashi is often cited by papers focused on Renal cell carcinoma treatment (12 papers), Renal and related cancers (9 papers) and Cancer Genomics and Diagnostics (8 papers). Riuko Ohashi collaborates with scholars based in Japan, United States and Switzerland. Riuko Ohashi's co-authors include Takao Hamakubo, Makoto Naito, Tatsuhiko Kodama, Takeshi Kawamura, Hiroko Iwanari, Keiko Horiuchi, Holger Moch, Shuying Jiang, Go Hasegawa and Hiroko Iwanari and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Riuko Ohashi

65 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Riuko Ohashi Japan 22 858 426 371 287 212 72 1.7k
Hideo Takeshima Japan 25 765 0.9× 207 0.5× 317 0.9× 219 0.8× 248 1.2× 123 2.3k
Stefanie Koidl Germany 12 1.3k 1.5× 349 0.8× 161 0.4× 265 0.9× 491 2.3× 15 2.1k
Fengrong Zuo United States 15 742 0.9× 197 0.5× 595 1.6× 257 0.9× 265 1.3× 16 1.7k
Karl X. Chai United States 24 796 0.9× 253 0.6× 218 0.6× 278 1.0× 270 1.3× 48 1.6k
Borja Sáez United States 22 1.7k 2.0× 492 1.2× 272 0.7× 432 1.5× 422 2.0× 41 2.8k
Hirotaka Koizumi Japan 20 635 0.7× 207 0.5× 266 0.7× 169 0.6× 355 1.7× 53 1.4k
Axel Vater Germany 21 886 1.0× 472 1.1× 347 0.9× 112 0.4× 294 1.4× 39 1.8k
Lynn Vitale‐Cross United States 16 824 1.0× 174 0.4× 212 0.6× 276 1.0× 537 2.5× 22 1.5k
Kristy Red-Horse United States 18 1.2k 1.4× 1.1k 2.6× 270 0.7× 294 1.0× 278 1.3× 25 2.9k
Zeyang Ding China 28 853 1.0× 208 0.5× 279 0.8× 474 1.7× 429 2.0× 92 1.8k

Countries citing papers authored by Riuko Ohashi

Since Specialization
Citations

This map shows the geographic impact of Riuko Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riuko Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riuko Ohashi more than expected).

Fields of papers citing papers by Riuko Ohashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riuko Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riuko Ohashi. The network helps show where Riuko Ohashi may publish in the future.

Co-authorship network of co-authors of Riuko Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Riuko Ohashi. A scholar is included among the top collaborators of Riuko Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riuko Ohashi. Riuko Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shimada, Yoshifumi, Shuhei Kondo, Riuko Ohashi, et al.. (2024). Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer. Human Pathology. 145. 71–79.
3.
Notohara, Kenji, Mitsuko Nakashima, Masuo Ujita, et al.. (2023). Multiple hemangiomas (hepatic small vessel neoplasia) in the liver with Budd-Chiari syndrome. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(6). 1085–1089. 1 indexed citations
4.
Lobo, João, Riuko Ohashi, Mahul B. Amin, et al.. (2022). WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Histopathology. 81(4). 426–438. 61 indexed citations
5.
Ueki, Yushi, Riuko Ohashi, Manabu Takeuchi, et al.. (2022). Predicting Cervical Lymph Node Metastasis Following Endoscopic Surgery in Superficial Head and Neck Carcinoma. Frontiers in Surgery. 8. 813260–813260. 2 indexed citations
6.
Uematsu, Kohya, Takashi Ushiki, Hajime Ishiguro, et al.. (2021). Osteoclastogenic Potential of Tissue-Engineered Periosteal Sheet: Effects of Culture Media on the Ability to Recruit Osteoclast Precursors. International Journal of Molecular Sciences. 22(4). 2169–2169. 1 indexed citations
7.
Lobo, João, Riuko Ohashi, Birgit Helmchen, et al.. (2021). The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth. Biomedicines. 9(10). 1418–1418. 21 indexed citations
8.
Ohashi, Riuko, Akira Horii, Kazuto Hoshi, et al.. (2020). Photosensitizer With Illumination Enhances In Vivo Antitumor Effect of Anti-ROBO1 Immunotoxin on Maxillary Sinus Squamous Cell Carcinoma. Anticancer Research. 40(7). 3793–3799. 3 indexed citations
9.
Ohashi, Riuko, Peter Schraml, Niels J. Rupp, et al.. (2019). Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma. Translational Oncology. 12(9). 1131–1137. 11 indexed citations
10.
Ohashi, Riuko, Jan H. Rüschoff, Christian Beisel, et al.. (2019). Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma. Neoplasia. 21(2). 247–256. 47 indexed citations
11.
Sato, Miyuki, Satoshi Watanabe, Hiroshi Tanaka, et al.. (2019). Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations. PLoS ONE. 14(4). e0215292–e0215292. 10 indexed citations
12.
Moch, Holger, Riuko Ohashi, Jatin Gandhi, & Mahul B. Amin. (2018). Morphological clues to the appropriate recognition of hereditary renal neoplasms. Seminars in Diagnostic Pathology. 35(3). 184–192. 7 indexed citations
13.
Jiang, Shuying, Koichi Matsubara, Riuko Ohashi, et al.. (2014). Differential expression of pentraxin 3 in neutrophils. Experimental and Molecular Pathology. 98(1). 33–40. 21 indexed citations
14.
Horiuchi, Keiko, Takeshi Kawamura, Hiroko Iwanari, et al.. (2013). Identification of Wilms' Tumor 1-associating Protein Complex and Its Role in Alternative Splicing and the Cell Cycle. Journal of Biological Chemistry. 288(46). 33292–33302. 287 indexed citations
15.
Savchenko, A.S., Akira Inoue, Riuko Ohashi, et al.. (2011). Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Pathology International. 61(5). 290–297. 66 indexed citations
16.
Jiang, Shuying, Riuko Ohashi, A.S. Savchenko, et al.. (2009). Protein expression of nuclear receptors in human and murine tissues. Pathology International. 59(2). 61–72. 5 indexed citations
17.
18.
Imamura, Masaru, Takashi Kawasaki, A.S. Savchenko, et al.. (2007). Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages. Cellular Immunology. 248(2). 86–94. 35 indexed citations
19.
Okudela, Koji, Masaya Suzuki, Shinji Kageyama, et al.. (2007). PIK3CA mutation and amplification in human lung cancer. Pathology International. 57(10). 664–671. 110 indexed citations
20.
Tanaka, Masamitsu, Riuko Ohashi, Ritsuko Nakamura, et al.. (2004). Tiam1 mediates neurite outgrowth induced by ephrin‐B1 and EphA2. The EMBO Journal. 23(5). 1075–1088. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideo Takeshima Breakdown of academic impact, for papers by Stefanie Koidl Breakdown of academic impact, for papers by Fengrong Zuo Breakdown of academic impact, for papers by Karl X. Chai Breakdown of academic impact, for papers by Borja Sáez Breakdown of academic impact, for papers by Hirotaka Koizumi Breakdown of academic impact, for papers by Axel Vater Breakdown of academic impact, for papers by Lynn Vitale‐Cross Breakdown of academic impact, for papers by Kristy Red-Horse Breakdown of academic impact, for papers by Zeyang Ding
Rankless by CCL
2026